Normal vision requires the precise control of vascular growth to maintain corneal transparency. Here we provide evidence for a unique mechanism by which the Forkhead box transcription factor FoxC1 regulates corneal vascular development. Murine Foxc1 is essential for development of the ocular anterior segment, and in humans, mutations have been identified in Axenfeld-Rieger syndrome, a disorder characterized by anterior segment dysgenesis. We show that FOXC1 mutations also lead to corneal angiogenesis, and that mice homozygous for either a global (Foxc1
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avascularity | soluble form of VEGF receptor 1 | VEGF bioavailablility P athological angiogenesis occurs in a wide range of disorders (1), including highly prevalent causes of blindness (2-4). In the cornea, such neovascularization or abnormal growth of blood vessels from the limbus into the adjacent (normally avascular) corneal stroma is sight-threatening (5-7). Thus, an adequate understanding of the mechanisms by which the stroma impedes vascular growth and maintains corneal transparency is important for vision and the development of new therapies. Furthermore, the avascular nature of the cornea provides an excellent model for studying the regulation of angiogenesis, offering insights potentially applicable to multiple diseases and tissues. Here we present findings from human and murine studies of Forkhead box (Fox) transcription factor FoxC1* that reveal a novel mechanism of regulating corneal avascularity.
To better understand the molecular and cellular mechanisms that control abnormal vascular growth in disease, the roles of angiogenic factors such as VEGF have been studied intensively (8) . This led to recognition that in the eye, expression of a soluble form of VEGF receptor 1 (sVEGFR-1) represents a potent natural inhibitor of corneal angiogenesis (9) . More broadly, numerous clinical trials are underway to investigate the efficacy of antiangiogenic agents that block VEGF signaling, and several angiogenesis inhibitors have been approved for oncologic and ocular disease therapy (10) . Although neovascularization is known to be tightly regulated by a balance between proangiogenic and antiangiogenic factors, the precise mechanism(s) by which pathological angiogenesis occurs in multiple diseases, including the angiogenically privileged cornea, remain incompletely understood.
Our study centers on FoxC1, a member of the large Forkhead box transcription factor family, which has essential roles in development and disease. Fox genes regulate an array of fundamental processes, including cell fate determination, proliferation, and differentiation (11) (12) (13) (14) . Of note, some family members, including Foxc1, have recently been implicated in vascular development (15, 16) . These genes' closely related functions in multiple species (13, 14) correspond with evolutionary conservation of the forkhead (DNA binding) domain from yeast to humans and illustrate the value of model organism analyses for characterizing human disease mechanisms. Such approaches allowed identification of common causative pathways for the two main phenotypes thus far attributed to FOXC1 mutation or gene dosage changes: Axenfeld-Rieger syndrome (ARS) and cerebellar/ posterior fossa malformations. Perturbed neural crest (NC) function is central to both groups of disorders (17, 18) , with the central nervous system malformations secondary to altered retinoic acid signaling from NC-derived meninges (19) (20) (21) .
ARS comprises a range of malformations affecting primarily the iris and the iridocorneal angle, through which the aqueous humor drains (22) (23) (24) (25) (26) , with comparable phenotypes observed in heterozygous Foxc1 null mutant (Foxc1 +/− ) mice (27) . Homozygous null mutant (Foxc1 −/− ) mice exhibit more severe anomalies, including disorganization of the corneal stromal extracellular matrix (ECM) and failure of corneal endothelial and anterior chamber formation (28, 29) . These severe corneal phenotypes correspond to initial Foxc1 expression in presumptive corneal mesenchyme cells (located between the corneal epithelium and the lens) and, subsequently, in stromal cells. Of note, the great majority of these Foxc1-expressing cells are NC-derived (30) .
Corneal transparency, which is an essential prerequisite for normal vision, requires precise control and inhibition of blood vessel growth. Here we present findings from human and murine studies that have identified FoxC1 as a key component of the mechanisms that maintain corneal avascularity. We report that patients with FOXC1-attributable ARS have pathological corneal angiogenesis, comparable to the anterior segment anomaly and angiogenesis phenotypes present in mice carrying either conventional null mutations (global Foxc1 −/− ) or Foxc1-null mutations confined to the NC cells (NC-specific Foxc1 −/− ), which give rise to To whom correspondence should be addressed. E-mail: t-kume@northwestern.edu.
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*Gene names are in all uppercase letters for human genes (e.g., FOXC1). Only the first letter is capitalized for mouse genes (e.g., Foxc1), and the first and subclass letters are capitalized for all chordates (e.g., FoxC1) (55).
the corneal stroma. Although homozygous Foxc1 murine mutants die at birth, their corneas are extensively vascularized and have perturbed ECM and elevated levels of several proangiogenic matrix metalloproteinases (MMPs). Heterozygous mutant mice survived through adulthood, and although their corneas were avascular, their limbal vasculature was disrupted, and the growth of vessels after corneal alkali burn injury was enhanced. This amplification of the angiogenic response was abolished by inhibition of VEGF signaling. These results identify a previously unknown mechanism by which FoxC1 regulates vessel growth, and suggest that targeting FoxC1 may represent a useful strategy for developing novel therapies to combat blindness as well as other diseases involving pathological angiogenesis.
Results

FOXC1-Attributable ARS Is Associated with Corneal Angiogenesis.
Here we demonstrate that patients with ARS attributable to either FOXC1 mutation or altered dosage exhibit corneal neovascularization. Affected individuals from an ARS pedigree secondary to a 29-kb FOXC1-encompassing deletion (19, 31) ( Segment. Recent murine cell fate mapping studies show that the majority of corneal stromal and endothelial cells are NC-derived (30, 32) , as are the great majority of Foxc1-expressing cells in the eye (30) . Thus, we began our investigation of the cell type-specific functions of Foxc1 during embryonic development by generating mice with a conditional, NC-specific, Foxc1-null mutation (Wnt1-Cre;Foxc1 F/F ). These mice exhibit a 97% reduction in Foxc1 expression compared with controls (Foxc1 (Fig. S2A ). Mice heterozygous for the NC-specific Foxc1-null mutation (NC-Foxc1 +/− ) survived to adulthood, but some (5 of 11) had abnormally shaped and/or positioned pupils ( Fig. 2A) , reminiscent of ARS patients with heterozygous FOXC1 mutations. NC-Foxc1 −/− mice died postnatally with hydrocephalus and craniofacial abnormalities comparable to those seen in conventional Foxc1 −/− mice (29) . Although NC cells migrate normally to the eyes of NC-Foxc1 +/− and NC-Foxc1 −/− embryos (Fig. S3) , collagen matrix accumulation and anterior segment formation is severely impaired (Fig. 2B) . Ultrastructural analysis of the corneal stroma of NC-Foxc1 −/− mice revealed abnormally shaped and less-ordered mesenchymal cells, with collagen deposited in swirls (Fig. 2C) . Furthermore, whereas mutant corneal epithelium remains positive for keratin 14, alterations in NC-Foxc1 −/− mice include failure of corneal endothelial formation (i.e., absence of N-cadherin + cells), an absent anterior chamber, severely disorganized and thickened corneal stroma (Fig. S4A) , hypoplasia of the prospective trabecular meshwork and iris ( Fig. S4 B and C) , and impaired iris smooth muscle differentiation (i.e., decreased staining of smooth muscle α-actin) (Fig. S4D) , all of which are in agreement with findings in conventional Foxc1 −/− mutants (28, 29) . These data demonstrate that Foxc1 is essential for NC-dependent formation of the ocular anterior segment.
Foxc1 in the NC Is Required to Maintain Corneal Transparency by
Preventing Blood and Lymphatic Vessel Growth. The developmental anomalies observed in NC-specific and conventional Foxc1-null mice were accompanied by corneal neovascularization. Ectopic outgrowth of CD31 + blood vessels from limbal vessels was observed in NC-Foxc1 −/− (Fig. S5A and Fig. 3A ) and Foxc1 −/− (Fig.  S5B ) embryos starting at embryonic day 14.5 (E14.5). In NCFoxc1 −/− embryos, the blood vessels formed a fine vascular network across the entire cornea by postnatal day 0 (P0), and limbal vessels were severely disrupted (Fig. 3A) . NC-Foxc1 +/− mice exhibited partially disrupted limbal vessels, but their corneas, like those of control (Foxc1 F/F ) mice, remained avascular through adulthood (Fig. 3A) . Consistently, adult NC-Foxc1 +/− mice exhibited increased sprouting of blood vessels at the limbus (Fig.  3 A and C) . Corneal avascularity also was observed after the conditional deletion of Foxc1 expression in murine vascular endothelial cells (29, (33) (34) (35) (36) (Figs. S2B and S6) . Collectively, these data demonstrate that deficiency of Foxc1 expression in NCderived corneal stroma cells, but not vascular endothelial cells, induces subsequent corneal angiogenesis. Furthermore, in view of the comparable human and murine phenotypes, this key role in preserving corneal avascularity during embryonic development is evolutionarily conserved.
Because lymphangiogenesis generally parallels angiogenesis (7, 37, 38) , we next evaluated the growth of lymphatic vessels in NC-Foxc1 mutant mice. At E17.5 and P0, Prox1 + and Lyve1 + lymphatic vessels extended from the limbus into the cornea of NC-Foxc1 −/− mice (Fig. 3B) . The corneas of NC-Foxc1 +/− mice and control (Foxc1 F/F ) mice remained avascular through adulthood, but the limbal lymphatic vessels of NC-Foxc1 +/− embryos (E17.5) and adults were partially disrupted. Similar to the limbal blood vessels, lymphatic sprouting from the limbus of adult NC-Foxc1 +/− mice was significantly increased (Fig. 3 B and C) . Thus, NC-Foxc1-deficient mice exhibit a dose-dependent effect on vascular growth, and angiogenesis (E14.5) precedes lymphangiogenesis (E17.5), which mirrors the sequential induction of corneal angiogenesis and lymphangiogenesis by VEGF-A (39). Collectively, these findings indicate that Foxc1 appears to maintain corneal transparency by preventing both blood vessel and lymphatic vessel growth during embryonic development.
Foxc1 Regulates MMP Expression in the Corneal Stroma. NC-Foxc1 deficiency did not alter corneal protein levels of VEGF-A or fibroblast growth factor (FGF)-2, which are frequently up-regulated during vascular growth, and was associated with increased sVEGFR-1 (or sFlt-1), an antiangiogenic factor (9, 40). However, several MMPs (e.g., MMP3, MMP9, and MMP19) were remarkably up-regulated in the corneas of NC-Foxc1-deficient mice (Fig. S7 and Fig. 4) . MMPs degrade the ECM, possibly explaining the severely disorganized corneal ECM in NC-Foxc1 −/− mice ( Fig.  2 B and C) despite normal expression levels of collagens, such as Col1a1 (Fig. S7 ). These observations also are consistent with the function of parologous Forkhead genes, which modulate MMP9 expression during cell migration and malignancy (41) (42) (43) . These findings suggest that elevated MMP levels result in degraded ECM in the cornea of NC-Foxc1 −/− mice.
Heterozygous Foxc1 Mutations Enhance Growth of Blood and Lymphatic
Vessels After Corneal Alkali Burn Injury. Alkali burns represent an extreme corneal injury, inducing pathological angiogenesis in both mice and humans. To determine whether Foxc1 has a role in the growth of corneal vessels in adult mice, we evaluated the angiogenic response to alkali burn injury (44, 45) in NC-Foxc1
and Foxc1 +/− mice because of the perinatal lethality associated with the homozygous mutation. At 14 d after injury, corneal CD31 + blood vessel networks were significantly more extensive in both NC-Foxc1 +/− and Foxc1 +/− mice compared with their respective controls (Foxc1 F/F and WT) (Fig. 5) . The heterozygous mutations also demonstrated increased growth of lymphatic (Lyve-1 + ) vessels (Fig. 5 ) and up-regulated corneal MMP9 expression in NC-Foxc1 +/− mice relative to controls (Fig. S8 ). Taken together with the observation of corneal angiogenesis in patients with FOXC1 mutations (Fig. 1) , these findings suggest a requirement for FoxC1 in keeping the postnatal cornea devoid of blood and lymphatic vessels.
Increased Angiogenic Response Attributable to Foxc1 Haploinsufficiency
Is Abolished by Blockade of VEGF Signaling. Because several MMPs regulate the extracellular bioavailability of VEGF via proteolytic release or cleavage from the ECM (46) (47) (48) , and because corneal MMP levels are up-regulated by the loss of Foxc1 in NCderived stromal cells (Fig. 4 and Figs. S7 and S8) , we investigated whether VEGF signaling contributes to the enhanced vascular growth observed in NC-Foxc1 +/− mice after corneal injury. Daily i.p. injections of SU5416, a VEGF receptor 2 (VEGFR-2) tyrosine kinase inhibitor (49, 50) , after corneal alkali burn injury significantly reduced the growth of CD31 + blood vessels at day 7 postinjury, abolishing the difference between control and NC-Foxc1 +/− mice ( Fig. 6 A and B) . Because angiogenesis and lymphangiogenesis are induced by different VEGF concentrations (39) , and corneal lymphangiogenesis is less robust than angiogenesis after corneal injury (Fig. 6 A and  B) , the lack of an effect of SU5416 on lymphangiogenesis might be attributable to SU5416 dosage. Taken together, these data indicate that stromal Foxc1 suppresses corneal neovascularization, at least in part, by blocking the angiogenic response to VEGF.
Discussion
Although much progress has been made toward defining the mechanisms underlying neovascularization, including identification of the antiangiogenic role of sVEGFR-1 in limiting corneal vessel growth (9) , the pathogenesis of corneal angiogenesis remains incompletely understood. The findings reported here identify a second, complementary mechanism that maintains corneal transparency through the FoxC1-mediated regulation of ECM alterations and subsequent VEGF-mediated angiogenesis (Fig. 6C) . This interpretation is supported by phenotypic observations in patients with a spectrum of FOXC1 variations and in mice with global and NC-specific Foxc1 alterations. The present study provides evidence that Foxc1 in the NC plays a specific role in ocular development. NC-specific Foxc1 +/− mice have abnormally shaped pupils ( Fig. 2A) , whereas NCspecific Foxc1 −/− mice have abnormal formation of the ocular anterior segment, including severely disorganized corneal stroma (Fig. 2 B and C) and corneal neovascularization (Fig. 3 and Fig. S5 ). These ocular abnormalities are very similar to those seen in global Foxc1 −/− mutant mice and are consistent with the observation that the majority of Foxc1-expressing cells in the periocular mesenchyme of the mouse embryo are NC-derived (30) . This finding also suggests that the corneal neovascularization seen in patients with FOXC1 variations is likely caused by impairment of NC-derived corneal stroma.
One striking phenotype of corneal defects in NC-specific Foxc1 −/− mice during embryonic development is the significant up-regulation of MMPs, including MMP3, MMP9, and MMP19 (Fig. 4 and Fig. S7 ). These mutants have abnormal ECM in the corneal stroma with normal expression of collagen genes, ) embryos and mice were avascular with developing long ciliary arteries (long arrows) and limbal blood vessels (short arrows). The corneas of NC-Foxc1 +/− embryos and mice remained avascular through adulthood, but the long ciliary arteries (long arrows) and limbal blood vessels (Inset; short arrow) of embryos and newborn mice were disrupted. Increased sprouting of limbal blood vessels (arrowheads) was observed in adult NC-Foxc1 +/− mice. In NC-Foxc1 −/− embryos, corneal vascularization (red arrows) was observed by E14.5 and extended throughout the cornea at later time points; the disruption of limbal blood vessels was apparent on E17.5 and P0. (B) NCspecific loss of Foxc1 increases the growth of corneal lymphatic vessels in mice. Lymphangiogenesis was evaluated in corneas from control (Foxc1
, and NC-Foxc1 −/− embryos (E17.5) and newborn mice (P0), and also from adult (7-wk-old and 43-wk-old) Foxc1 F/F and NC-Foxc1 +/− mice. Embryonic corneas were stained with the lymphatic vessel marker Prox1, corneas from newborn mice were stained with Prox1 or the lymphatic vessel marker Lyve-1, and corneas from adult mice were stained with Lyve-1. Growth of lymphatic vessels from the limbus (red arrow) into the cornea was observed in NC-Foxc1 suggesting that excessive proteolytic ECM degradation is caused by the elevated MMP levels. Because MMP-mediated ECM degradation is involved in pathological neovascularization (51) , this process may lead to the outgrowth of blood and lymphatic vessels from the limbus (Fig. 6C) . We found consistently increased MMP9 expression in the corneal stroma of NC-specific Foxc1 +/− mice after alkali burn injury compared with controls (Fig. S8) .
The inhibition of corneal angiogenesis in NC-specific Foxc1 +/− mice observed with VEGF blockade (Fig. 6 A and B) indicates that Foxc1 haploinsufficiency in the NC enhances VEGF-dependent corneal neovascularization. Although VEGF expression is not altered in the corneas of NC-specific Foxc1 mutants, and the antiangiogenic molecule sVEGFR-1 is up-regulated (Fig. 4 and Fig. S7 ), MMPs have been shown to enhance VEGF bioavailability in the ECM (51, 52) . Thus, it is highly likely that Foxc1 deficiency, by elevating MMP levels, shifts the delicate balance between proangiogenic and antiangiogenic factors, thereby inducing neovascularization from the limbus (Fig. 6C) . The conserved function of FoxC1 in corneal angiogenesis between human and mouse has intriguing parallels to the contribution of altered FOXC1 levels to decreased breast cancer survival (53, 54), a phenomenon in which tumor neovascularization plays Mice were treated with DMSO (control) or the VEGFR-2 blocker SU5416 for 7 consecutive days after corneal alkali burn injury, after which angiogenesis and lymphangiogenesis were evaluated in corneas stained for CD31 (red) and Lyve-1 (green) expression, respectively, on day 7 after corneal injury. The blockade of VEGFR-2 dramatically reduced the growth of corneal blood vessels but not that of lymphatic vessels. (B) The blood vessel area, but not the lymphatic vessel area, was significantly smaller after treatment with SU5416 than after DMSO treatment. Values are mean ± SEM. CI, corneal injury; NS, not significant. *P < 0.05, Student t test. (Scale bars: 100 μm.) (C) Model for FoxC1 function in corneal transparency. FoxC1 is essential for the establishment and maintenance of corneal avascularity during development and in postnatal life by regulating MMP expression in corneal stroma. Corneal avascularity is tightly controlled by angiogenic and antiangiogenic responses. In Foxc1-mutant corneas, elevated MMP levels degrade ECM and enhance VEGF bioavailability, thereby inducing corneal neovascularization, whereas sVEGFR1 suppresses activation of VEGF signaling by neutralizing VEGF.
a central role (1, 8) . If dysregulated FoxC1 expression contributes to abnormal angiogenesis in multiple tissues, then our identification of a specific target for combating corneal angiogenesis may offer insight into a variety of conditions characterized by pathological neovascularization.
Materials and Methods
Studies included immunohistochemistry, real-time RT-PCR, corneal flat mounting, and corneal alkali burn injury. Detailed information is provided in SI Materials and Methods. PCR primer sequences are listed in Table S1 .
